Lucas Ward
Stock Analyst at Ascendiant Capital
(0.54)
# 4,104
Out of 5,072 analysts
24
Total ratings
25%
Success rate
-31.02%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SXTP 60 Degrees Pharmaceuticals | Maintains: Buy | $3 → $2.8 | $1.02 | +174.51% | 4 | Nov 28, 2025 | |
| ACON Aclarion | Maintains: Buy | $22 → $23 | $6.25 | +268.00% | 5 | Nov 20, 2025 | |
| LIQT LiqTech International | Maintains: Buy | $4 → $4.2 | $1.90 | +121.05% | 6 | Nov 20, 2025 | |
| HSCS HeartSciences | Maintains: Buy | $15 → $9 | $2.58 | +248.84% | 3 | Oct 1, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $6.2 → $6.5 | $2.26 | +187.61% | 4 | Sep 9, 2025 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $3,375 → $2,700 | $1.23 | +219,412.20% | 2 | Jul 29, 2024 |
60 Degrees Pharmaceuticals
Nov 28, 2025
Maintains: Buy
Price Target: $3 → $2.8
Current: $1.02
Upside: +174.51%
Aclarion
Nov 20, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $6.25
Upside: +268.00%
LiqTech International
Nov 20, 2025
Maintains: Buy
Price Target: $4 → $4.2
Current: $1.90
Upside: +121.05%
HeartSciences
Oct 1, 2025
Maintains: Buy
Price Target: $15 → $9
Current: $2.58
Upside: +248.84%
Vivos Therapeutics
Sep 9, 2025
Maintains: Buy
Price Target: $6.2 → $6.5
Current: $2.26
Upside: +187.61%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $3,375 → $2,700
Current: $1.23
Upside: +219,412.20%